Back View on Grants.gov

Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)

HHS-NIH11 RFA-DA-27-015
Posted: May 21, 2026 12:00:00 AM EDT
Closes: 09/30/2026
Views: 85

Funding Information

Estimated Total Funding
$3,000,000
Expected Number of Awards
1

Description

The purpose of this notice of funding opportunity (NOFO) is to establish a Center that trains researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics and to advance the best concepts through initial experiments via technical and financial support.

Synopsis

The purpose of this notice of funding opportunity (NOFO) is to establish a Center that trains researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics and to advance the best concepts through initial experiments via technical and financial support.

Eligibility

Eligible Applicants:
Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification) Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education State governments Special district governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments City or township governments Private institutions of higher education Small businesses Native American tribal governments (Federally recognized) For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Funding Activity Categories

Health

CFDA Numbers

  • 93.279 - Drug Use and Addiction Research Programs

Contact Information

Agency: National Institutes of Health
Contact: National Institutes of Health
Email: nidagmbemail@nida.nih.gov
Phone: 301-402-2541
Tam Nguyen, PhD
nidagmbemail@nida.nih.gov

Additional Information

Document Type: synopsis
Opportunity Category: Discretionary
Version: 1
Last Updated: May 21, 2026 07:26:49 AM EDT

Related Opportunities

State Veterans Home Construction Grant Program
$275,000,000
VA-CSHF Due: Open Submission
Improving Oversight of Federal GrantmakingVA is required to ensure compliance with all applicable statutes, regulations, and Executive Orders when evaluating and awarding grants. In accordance with Executive Order 14332, Improving Oversight of Federa...
Notice of Intent to Publish a Funding Opportunity Announcement for Morris K. Udall Discovery Centers without Walls (DCWoW) for Parkinson's Disease Research (RM1 - Clinical Trial Optional)
HHS-NIH11 Due: Open Submission
HEAL: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
HHS-NIH11 Due: Open Submission
Forecast to Publish a Funding Opportunity Announcement for Copy of Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource Core (U24) (Clinical Trial Optional)
HHS-NIH11 Due: Open Submission
Forecast to Publish a Funding Opportunity Announcement for Copy of Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24) (Clinical Trial Optional)
HHS-NIH11 Due: Open Submission
View All Opportunities from HHS-NIH11

Ask Questions